Anti-VEGF Recombinant Antibody Products

Loading...

Anti-VEGF Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

Creative Biolabs leads the industry in biotechnological innovation, providing a superior range of anti-VEGF recombinant antibody products tailored for global research and therapeutic advancement. Our expertly designed antibodies deliver exceptional specificity and high affinity, enabling scientists worldwide to confidently pursue their critical investigations and accelerate drug discovery.

VEGF: A Pivotal Target for Angiogenesis-Related Therapies

Vascular Endothelial Growth Factor (VEGF) is a highly conserved signaling protein crucial for vasculogenesis and angiogenesis, playing a pivotal role in both physiological processes and various pathological conditions. Extensive research has elucidated its central involvement in tumor growth, metastasis, and ocular diseases like age-related macular degeneration (AMD) and diabetic retinopathy. Understanding and targeting VEGF pathways are therefore paramount for developing effective treatments for a wide range of angiogenesis-dependent diseases.

Alternative Names

Vascular endothelial growth factor; vascular permeability factor; VPF; MVCD1; L-VEGF.

Background

Vascular endothelial growth factor (VEGF), originally known as vascular permeability factor (VPF), is a signal protein produced by cells that stimulates vasculogenesis and angiogenesis. It is part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. Serum concentration of VEGF is high in bronchial asthma and diabetes mellitus. VEGF's normal function is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels.

Anti-VEGF rAb Products

Creative Biolabs' anti-VEGF recombinant antibody products are meticulously developed using advanced genetic engineering techniques, ensuring high purity, lot-to-lot consistency, and exceptional specificity. These antibodies offer superior binding affinity and functional activity, making them ideal tools for a diverse array of applications, from fundamental research to preclinical drug development. Their recombinant nature guarantees a reliable and scalable supply, free from animal-derived contaminants.

Table 1. Featured anti-VEGF recombinant antibody products at Creative Biolabs.

Creative Quality Control

At Creative Biolabs, the commitment to quality constitutes a fundamental principle, meticulously integrated across all phases of the production process. Rigorous quality control measures are systematically applied to all anti-VEGF recombinant antibody products, encompassing comprehensive characterization through advanced analytical techniques. Furthermore, each production lot undergoes exhaustive validation for purity, identity, potency, and endotoxin levels, thereby ensuring optimal performance and uncompromising safety for critical research applications.

Customer Reviews

Excellent

Ma***i
Human Anti-VEGF Recombinant Antibody (HPAB-2817LY) (HPAB-2817LY)

The anti-VEGF recombinant antibody from Creative Biolabs proved instrumental in advancing our angiogenesis research. Its high specificity and consistent performance significantly optimized our experimental workflows, leading to considerable efficiencies.

28/May/2025

Excellent

Si***a
Recombinant Human Anti-VEGF Antibody (Fab-12) (PABX-185)

We've incorporated Creative Biolabs' anti-VEGF antibodies into our therapeutic development pipeline, and the results have been consistently reliable. The product's stability and activity are outstanding, making it an indispensable tool for our preclinical studies.

01/Jun/2025

Excellent

Ba***d
Human Anti-VEGF Recombinant Antibody (PABX-186) (PABX-186)

The technical support from Creative Biolabs was exceptional, guiding us through product selection and application. Their anti-VEGF recombinant antibody delivered precise and reproducible data, exceeding our expectations for our in vivo models.

15/Jun/2025

rAb Production

Creative Biolabs utilizes cutting-edge mammalian cell expression systems and advanced purification techniques to produce our anti-VEGF recombinant antibodies. This robust production platform ensures the generation of highly pure, functionally active antibodies with excellent batch-to-batch consistency. Our scalable manufacturing capabilities allow us to meet diverse project requirements, from small-scale research needs to large-scale therapeutic development.

Featured Anti-VEGF Recombinant Antibody Production Platforms
Fig.7 Milligram-scale anti-VEGF recombinant antibody production.

Fig.8 Gram-scale anti-VEGF recombinant antibody production.

rAb Modalities

Our anti-VEGF recombinant antibody products are available in multiple modalities, including various isotype formats and conjugation options, providing unparalleled flexibility for diverse research and therapeutic applications.

Fig.9 Full-length anti-VEGF recombinant antibody production and modalities.

VEGF-Targeted Drug Information

Table 2. Public drug targeting VEGF.

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

At Creative Biolabs, we are dedicated to supporting your scientific endeavors with high-quality reagents. Our anti-VEGF recombinant antibody products are a testament to our expertise and commitment to advancing biological research and drug discovery. To learn more about our offerings or to discuss your specific project needs, please do not hesitate to get in touch with us. Our expert team is ready to assist you.

Related Diseases

Bladder Cancer

Rheumatoid Arthritis